PINK1 mutation heterozygosity and the risk of Parkinson's disease

被引:31
作者
Toft, M. [1 ]
Myhre, R.
Pielsticker, L.
White, L. R.
Aasly, J. O.
Farrer, M. J.
机构
[1] Norwegian Univ Sci & Technol, Dept Neurosci, N-7489 Trondheim, Norway
[2] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA
[3] Norwegian Univ Sci & Technol, Dept Lab Med, N-7034 Trondheim, Norway
[4] St Olavs Univ Hosp, Dept Neurol, Trondheim, Norway
关键词
D O I
10.1136/jnnp.2006.097840
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Mutations in the PTEN-induced kinase 1 (PINK1) gene have been identified in recessively inherited and sporadic early-onset parkinsonism (EOP). Methods: A total of 131 Norwegian patients diagnosed with Parkinson's disease were included. Of them, 89 participants had EOP (onset <= 50 years); the remaining had familial late-onset disease (mean age at onset 64 years). PINK1 analysis included sequencing and gene dose assessment. Mutations were examined in 350 controls. Results: Heterozygous missense mutations in PINK1 were found in 3 of 131 patients; none of the patients carried homozygous or compound heterozygous mutations. One of these three patients had a father affected by Parkinson's disease, and he carried the mutation. Three new and seven known polymorphic variants were identified, although none seemed to be associated with disease risk. Conclusions: PINK1 mutations are rare in Norwegian patients with EOP and familial Parkinson's disease. However, the data suggest that some heterozygous mutations might increase the risk of developing Parkinson's disease.
引用
收藏
页码:82 / 84
页数:3
相关论文
共 21 条
[1]   Clinical features of LRRK2-associated Parkinson's disease in Central Norway [J].
Aasly, JO ;
Toft, M ;
Fernandez-Mata, I ;
Kachergus, J ;
Hulihan, M ;
White, LR ;
Farrer, M .
ANNALS OF NEUROLOGY, 2005, 57 (05) :762-765
[2]   The role of pathogenic DJ-1 mutations in Parkinson's disease [J].
Abou-Sleiman, PM ;
Healy, DG ;
Quinn, N ;
Lees, AJ ;
Wood, NW .
ANNALS OF NEUROLOGY, 2003, 54 (03) :283-286
[3]   Genetics of Parkinson disease: paradigm shifts and future prospects [J].
Farrer, MJ .
NATURE REVIEWS GENETICS, 2006, 7 (04) :306-318
[4]   Diagnostic criteria for Parkinson disease [J].
Gelb, DJ ;
Oliver, E ;
Gilman, S .
ARCHIVES OF NEUROLOGY, 1999, 56 (01) :33-39
[5]   Novel PINK1 mutations in early-onset parkinsonism [J].
Hatano, Y ;
Li, YZ ;
Sato, K ;
Asakawa, S ;
Yamamura, Y ;
Tomiyama, H ;
Yoshino, H ;
Asahina, M ;
Kobayashi, S ;
Hassin-Baer, S ;
Lu, CS ;
Ng, AR ;
Rosales, RL ;
Shimizu, N ;
Toda, T ;
Mizuno, Y ;
Hattori, N .
ANNALS OF NEUROLOGY, 2004, 56 (03) :424-427
[6]  
Healy DG, 2004, NEUROLOGY, V63, P1486
[7]   Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease : Role of a single hit? [J].
Hedrich, Katja ;
Hagenah, Johann ;
Djarmati, Ana ;
Hiller, Anja ;
Lohnau, Thora ;
Lasek, Kathrin ;
Gruenewald, Anne ;
Hilker, Ruediger ;
Steinlechner, Susanne ;
Boston, Heather ;
Kock, Norman ;
Schneider-Gold, Christiane ;
Kress, Wolfram ;
Siebner, Hartwig ;
Binkofski, Ferdinand ;
Lencer, Rebekka ;
Muenchau, Alexander ;
Klein, Christine .
ARCHIVES OF NEUROLOGY, 2006, 63 (06) :833-838
[8]  
Hilker R, 2001, ANN NEUROL, V49, P367, DOI 10.1002/ana.74
[9]   Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa [J].
Ibáñez, P ;
Lesage, S ;
Lohmann, E ;
Thobois, S ;
De Michele, G ;
Borg, M ;
Agid, Y ;
Dürr, A ;
Brice, A .
BRAIN, 2006, 129 :686-694
[10]   Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism:: An 18F-dopa PET study [J].
Khan, NL ;
Valente, EM ;
Bentivoglio, AR ;
Wood, NW ;
Albanese, A ;
Brooks, DJ ;
Piccini, P .
ANNALS OF NEUROLOGY, 2002, 52 (06) :849-853